Scientific and Clinical Advisory Council
SafeMinds Scientific & Clinical Advisory Council is comprised of clinicians, health professionals, and scientists from a variety of disciplines, including, among others, specialists and experts in autism, environment, toxicology, pediatrics, neuroscience, pharmacology, and psychology.
José G. Dórea, Ph.D.
Professor of Nutritional Sciences, University of Brasília
A graduate of the University of Pernambuco with advanced degrees from the University of Massachusetts (MSc and PhD), Dr. Dorea has worked at Iowa State University (USA), University of Hawaii (USA), and University of Campinas (Brazil). He has authored numerous book chapters, and has published on infant nutrition and the environmental impact of toxic (natural and man made) substances on the growth and development of children. Dr. Dorea is on the editorial board of peer-reviewed scientific journals, and has authored and co-authored more than 180 papers in journals of public health, medical and environmental sciences, toxicology, and pharmacology.
Cindy Schneider, MD
Medical Director, Center for Autism Research and Education
Dr. Schneider is the Medical Director of CARE, the Center for Autism Research and Education. Her integrative medical practice is exclusively dedicated to individuals with autism and related neurological and immune disorders. Dr. Schneider’s areas of special interest include treatment of the immune, gastrointestinal, and metabolic aspects of autism and the identification of environmental toxins contributing to the autism epidemic. She has designed and implemented multiple research studies, and collaborated with researchers worldwide. Dr. Schneider’s priorities in both her medical practice and her research include the identification of the causes of autism, the formulation of effective treatment protocols, and the prevention of autism in future generations.
Dr. Schneider has served as a member of the Defeat Autism Now! think tank since 1997, and serves on the Clinician Advisory Committee at the Autism Research Institute. She was the founding president and medical director of two nonprofit organizations for autism research, and is a medical advisor for SafeMinds. Dr. Schneider has published extensively in the areas of genetic vulnerability to environmental toxins, and innovative treatments for the gastrointestinal and immune complications of autism.
As the mother of two children with autism and a leading authority in the field, Dr. Schneider closely tracks developments in autism research, and provides both a medical and personal assessment of current and promising treatment options.
Robert Sears, M.D.
Robert W. Sears, MD, FAAP, is a board-certified pediatrician in a full-time private practice in Dana Point, Calif. He received his medical degree from Georgetown University, and did his pediatric residency training at Childrens Hospital Los Angeles. “Dr. Bob,” as he likes to be called by his little patients, provides a unique blend of mainstream and integrative medical care. He is a co-author in the Sears Parenting Library, including The Baby Book and The Portable Pediatrician, and is the author of The Vaccine Book, The Autism Book, and HappyBaby: The Organic Guide to Baby’s First 24 Months. Dr. Bob has appeared on Dr. Oz, The Doctors, CNN, CBS Early Show, Fox Morning News, and Dr. Phil discussg parenting advice and pediatric health issues. He is a frequent speaker at parenting conferences, and serves on the medical advisory board for various organizations, including Talk About Curing Autism, Autism Care and Treatment Today, HappyBaby Organic Baby Food, and Kaplan University Department of Health Sciences. Dr. Bob is a contributor to AskDrSears.com, and regularly answers questions on his Mothering.com Ask the Experts forum.
Could Oxytocin be the Key to Normalizing Social Behavior in Autism?
Swiss researchers have discovered that a mutation of the neuroligin-3 gene disrupts the hormone oxytocin’s signaling pathway in the brains of mice causing reduced social interactions in the rodents. When the study’s authors repaired the oxytocin system of the mice using a pharmacological treatment their social behavior normalized. This exciting new finding may point to new pharmacological treatments focusing on improved social behavior for individuals with autism.
School-Based Mindfulness Program Shows Promise for Children with ASD
Many individuals with autism spectrum disorder (ASD) are faced with an additional challenge called executive dysfunction. A properly working executive function system provides a person with the ability to plan, problem solve, use working memory, monitor impulse control, manage inhibitions, make decisions, manage time, and initiate and scrutinize actions. However, these skills are typically missing in children with autism. Without proper executive functioning skills, classroom learning becomes especially difficult.
Autism Severity Can Change During Childhood
Does the degree of severity of autistic symptoms remain static during preschool and early elementary school years? If a change in severity is experienced, could the degree of variation be influenced by initial severity levels, sex, IQ or level of adaptive functioning? These thought-provoking questions were recently posed by a new study out of the MIND Institute at UC Davis.
COVID-19 Autism Resource Round-Up
The majority of American families have been at home for weeks due to the COVID-19 pandemic. At present time, there is no definitive end date for these orders. Signs point to individual states using a slow roll technique in order to re-open, which means a large number of autism families will continue to be at home for an indeterminate amount of time. In order to support special needs families during this challenging time, SafeMinds has assembled a comprehensive list of resources to make life at home more manageable. These resources have been broken down into different categories. Most categories include several links, giving many options to see what works best for your special needs family member.
Association Between Mitochondrial Dysfunction and Autism
Mitochondria are described by the Centers for Disease Control and Prevention (CDC) as “tiny parts of almost every cell in the body.” The CDC goes on to explain that mitochondria are the powerplants of cells, turning sugar and oxygen stored inside the body into energy, which cells need to function properly.
Individuals with Developmental Disabilities May Suffer More Severe COVID Outcomes
As the global pandemic continues to grow, concerning news originating from SUNY Upstate Medical University shows that COVID-19 appears to pose a greater threat to people with intellectual and developmental disabilities (IDD). The report published in Disability and Health Journal set out to compare COVID-19 outcomes among people with and without IDD through three different age spans.
